These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

867 related items for PubMed ID: 11329231

  • 1. The effect of a thiazolidinedione drug, troglitazone, on glycemia in patients with type 2 diabetes mellitus poorly controlled with sulfonylurea and metformin. A multicenter, randomized, double-blind, placebo-controlled trial.
    Yale JF, Valiquett TR, Ghazzi MN, Owens-Grillo JK, Whitcomb RW, Foyt HL.
    Ann Intern Med; 2001 May 01; 134(9 Pt 1):737-45. PubMed ID: 11329231
    [Abstract] [Full Text] [Related]

  • 2. Primary, secondary, tertiary, and quaternary treatment with troglitazone in type 2 diabetes mellitus in an outpatient clinical practice.
    Hershon KS, Hershon PM.
    Endocr Pract; 2000 May 01; 6(1):20-5. PubMed ID: 11419922
    [Abstract] [Full Text] [Related]

  • 3. Troglitazone monotherapy improves glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled study. The Troglitazone Study Group.
    Fonseca VA, Valiquett TR, Huang SM, Ghazzi MN, Whitcomb RW.
    J Clin Endocrinol Metab; 1998 Sep 01; 83(9):3169-76. PubMed ID: 9745421
    [Abstract] [Full Text] [Related]

  • 4. Differential effects of metformin and troglitazone on cardiovascular risk factors in patients with type 2 diabetes.
    Chu NV, Kong AP, Kim DD, Armstrong D, Baxi S, Deutsch R, Caulfield M, Mudaliar SR, Reitz R, Henry RR, Reaven PD.
    Diabetes Care; 2002 Mar 01; 25(3):542-9. PubMed ID: 11874944
    [Abstract] [Full Text] [Related]

  • 5. Troglitazone in combination with sulfonylurea restores glycemic control in patients with type 2 diabetes. The Troglitazone Study Group.
    Horton ES, Whitehouse F, Ghazzi MN, Venable TC, Whitcomb RW.
    Diabetes Care; 1998 Sep 01; 21(9):1462-9. PubMed ID: 9727892
    [Abstract] [Full Text] [Related]

  • 6. Triple therapy with glimepiride in patients with type 2 diabetes mellitus inadequately controlled by metformin and a thiazolidinedione: results of a 30-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Roberts VL, Stewart J, Issa M, Lake B, Melis R.
    Clin Ther; 2005 Oct 01; 27(10):1535-47. PubMed ID: 16330290
    [Abstract] [Full Text] [Related]

  • 7. Effect of troglitazone in insulin-treated patients with type II diabetes mellitus. Troglitazone and Exogenous Insulin Study Group.
    Schwartz S, Raskin P, Fonseca V, Graveline JF.
    N Engl J Med; 1998 Mar 26; 338(13):861-6. PubMed ID: 9516220
    [Abstract] [Full Text] [Related]

  • 8. Troglitazone, an insulin action enhancer, improves metabolic control in NIDDM patients. Troglitazone Study Group.
    Kumar S, Boulton AJ, Beck-Nielsen H, Berthezene F, Muggeo M, Persson B, Spinas GA, Donoghue S, Lettis S, Stewart-Long P.
    Diabetologia; 1996 Jun 26; 39(6):701-9. PubMed ID: 8781766
    [Abstract] [Full Text] [Related]

  • 9. A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin-treated type 2 diabetic patients.
    Yu JG, Kruszynska YT, Mulford MI, Olefsky JM.
    Diabetes; 1999 Dec 26; 48(12):2414-21. PubMed ID: 10580431
    [Abstract] [Full Text] [Related]

  • 10. Effect of combination therapy of troglitazone and sulphonylureas in patients with Type 2 diabetes who were poorly controlled by sulphonylurea therapy alone.
    Iwamoto Y, Kosaka K, Kuzuya T, Akanuma Y, Shigeta Y, Kaneko T.
    Diabet Med; 1996 Apr 26; 13(4):365-70. PubMed ID: 9162613
    [Abstract] [Full Text] [Related]

  • 11. Long-term effects of troglitazone: open-label extension studies in type 2 diabetic patients.
    Fonseca V, Foyt HL, Shen K, Whitcomb R.
    Diabetes Care; 2000 Mar 26; 23(3):354-9. PubMed ID: 10868865
    [Abstract] [Full Text] [Related]

  • 12. One-year glycemic control with a sulfonylurea plus pioglitazone versus a sulfonylurea plus metformin in patients with type 2 diabetes.
    Hanefeld M, Brunetti P, Schernthaner GH, Matthews DR, Charbonnel BH, QUARTET Study Group.
    Diabetes Care; 2004 Jan 26; 27(1):141-7. PubMed ID: 14693980
    [Abstract] [Full Text] [Related]

  • 13. Troglitazone add-on therapy to a combination of sulfonylureas plus metformin achieved and sustained effective diabetes control.
    Gavin LA, Barth J, Arnold D, Shaw R.
    Endocr Pract; 2000 Jan 26; 6(4):305-10. PubMed ID: 11242607
    [Abstract] [Full Text] [Related]

  • 14. Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: a randomized controlled trial.
    Fonseca V, Rosenstock J, Patwardhan R, Salzman A.
    JAMA; 2000 Apr 05; 283(13):1695-702. PubMed ID: 10755495
    [Abstract] [Full Text] [Related]

  • 15. Pioglitazone hydrochloride in combination with sulfonylurea therapy improves glycemic control in patients with type 2 diabetes mellitus: a randomized, placebo-controlled study.
    Kipnes MS, Krosnick A, Rendell MS, Egan JW, Mathisen AL, Schneider RL.
    Am J Med; 2001 Jul 05; 111(1):10-7. PubMed ID: 11448655
    [Abstract] [Full Text] [Related]

  • 16. Pioglitazone hydrochloride in combination with metformin in the treatment of type 2 diabetes mellitus: a randomized, placebo-controlled study. The Pioglitazone 027 Study Group.
    Einhorn D, Rendell M, Rosenzweig J, Egan JW, Mathisen AL, Schneider RL.
    Clin Ther; 2000 Dec 05; 22(12):1395-409. PubMed ID: 11192132
    [Abstract] [Full Text] [Related]

  • 17. A prospective, randomized comparison of the metabolic effects of pioglitazone or rosiglitazone in patients with type 2 diabetes who were previously treated with troglitazone.
    Khan MA, St Peter JV, Xue JL.
    Diabetes Care; 2002 Apr 05; 25(4):708-11. PubMed ID: 11919129
    [Abstract] [Full Text] [Related]

  • 18. [Combination therapy of insulin sensitizer, thiazolidinedione drugs, and sulfonylurea].
    Ohmura E, Hosaka D, Imai Y, Kawazu S.
    Nihon Rinsho; 2002 Sep 05; 60 Suppl 9():470-5. PubMed ID: 12387036
    [No Abstract] [Full Text] [Related]

  • 19. Troglitazone prevents the rise in visceral adiposity and improves fatty liver associated with sulfonylurea therapy--a randomized controlled trial.
    Katoh S, Hata S, Matsushima M, Ikemoto S, Inoue Y, Yokoyama J, Tajima N.
    Metabolism; 2001 Apr 05; 50(4):414-7. PubMed ID: 11288035
    [Abstract] [Full Text] [Related]

  • 20. A randomized, double-blind, placebo-controlled, clinical trial of the effects of pioglitazone on glycemic control and dyslipidemia in oral antihyperglycemic medication-naive patients with type 2 diabetes mellitus.
    Herz M, Johns D, Reviriego J, Grossman LD, Godin C, Duran S, Hawkins F, Lochnan H, Escobar-Jiménez F, Hardin PA, Konkoy CS, Tan MH.
    Clin Ther; 2003 Apr 05; 25(4):1074-95. PubMed ID: 12809958
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.